中心静脉接入装置并发症和血液恶性瘤患者的过早切除:一个多站点队列研究
Kerrie Curtis1,2,3, Samantha Keogh4,5, Meinir Krishnasamy1,6,7,8
1Department of Nursing University of Melbourne Melbourne Victoria Australia.
EJHaem
|March 26, 2025
概括
在患有血液性恶性瘤的患者中,中央静脉接入装置 (CVAD) 经常经历并发症和过早切除. 改善CVAD插入和管理对于更好的患者结果至关重要.
科学领域:
- 在瘤学瘤学.
- 血管接入装置 血管接入装置
- 血液学 血液学 血液学
背景情况:
- 中枢静脉接入装置 (CVAD) 对于在患有血性恶性瘤的患者中使用全身抗癌疗法 (SACT) 是必不可少的.
- 疾病和SACT增加了CVAD并发症的风险,导致治疗中断和不良结果.
研究的目的:
- 在患有血液性恶性瘤的患者中,在12个月的时间内全面描述CVAD的性能.
- 为了确定与CVAD并发症和早产相关的因素.
主要方法:
- 一项涉及673名患者和1078名CVAD在澳大利亚墨尔本四家三级医院的多站点队列研究.
- 收集的数据包括患者,设备,插入,维护,并发症和从健康和行政记录中删除的信息.
主要成果:
- 18%的CVAD保持在现场,而82%被移除,其中42%因感染或其他原因过早移除.
- 85%的CVAD有记录的并发症,这些并发症与提前切除的风险增加了两倍.
- CVAD类型,紧迫性,并发设备和插入技术与提前移除风险的增加有关.
结论:
- 在这个队列中,高比例的CVAD经历了并发症和过早切除.
- 临床实践和证据的不一致性为改善血液恶性瘤患者的CVAD结果提供了机会.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
09:57A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
12.1K
相关概念视频
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
74
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
74
Bone Marrow Sampling and Transplants
267
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
267
Disorders of Hemostasis
671
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
671
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
